AUROBINDO PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,131 INR | +2.53% |
|
+4.07% | +4.36% |
Business Summary
- generic drugs: for the treatment of neurological, cardiovascular, viral, gastroenterological, ophthalmologic and chronic diseases;
- active pharmaceutical ingredients.
At the end of March 2018, the group operated 23 production sites in India (19), the United States (3) and Brazil.
Net sales are distributed geographically as follows: India (12%), the United States (46.5%), Europe (31.2%) and other (10.3%).
Number of employees: 23,451
Sales per Business
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Generic Pharmaceuticals and Related Services
97.0
%
| 231,243 | 98.6 % | 241,044 | 97.0 % | +4.24% |
Services
2.1
%
| 2,422 | 1.0 % | 5,128 | 2.1 % | +111.67% |
Government Incentive Schemes
0.9
%
| 314 | 0.1 % | 2,176 | 0.9 % | +593.81% |
Scrap
0.1
%
| 197 | 0.1 % | 207 | 0.1 % | +5.03% |
Sales per region
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
45.2
%
| 105,208 | 44.9 % | 112,421 | 45.2 % | +6.86% |
Europe
29.1
%
| 78,813 | 33.6 % | 72,430 | 29.1 % | -8.10% |
Rest of the World
14.6
%
| 23,835 | 10.2 % | 36,222 | 14.6 % | +51.97% |
India
11.1
%
| 26,700 | 11.4 % | 27,482 | 11.1 % | +2.93% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 66 | 86-12-25 | |
| Director of Finance/CFO | - | 12-12-31 | |
B. Adi Reddy
CMP | Compliance Officer | - | 16-05-31 |
| Director/Board Member | - | 15-12-31 | |
| Corporate Officer/Principal | 68 | 00-01-31 | |
| Corporate Officer/Principal | 59 | 16-01-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 66 | 86-12-25 | |
| Founder | 66 | 86-12-25 | |
| Director/Board Member | 64 | 03-05-26 | |
| Director/Board Member | 39 | 07-09-26 | |
| Director/Board Member | 67 | 23-02-08 | |
| Director/Board Member | 64 | Feb. 09 | |
Savita Mahajan
BRD | Director/Board Member | 65 | 17-12-15 |
| Director/Board Member | 52 | 20-11-04 | |
| Director/Board Member | - | 15-12-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 585,938,609 | 280,869,458 ( 47.93 %) | 0 | 47.93 % |
Company contact information
Aurobindo Pharma Ltd.
Plot No. 1, Hyderabad Knowledge City Raidurg Panmaktha, Galaxy
500032, Hyderabad
+91 40 6672 5000
http://www.aurobindo.com
Group companies
| Name | Category and Sector |
|---|---|
Auronext Pharma Pvt Ltd.
 Auronext Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Aurobindo Pharma Ltd., Auronext Pharma Pvt Ltd. is a pharmaceutical company founded in 2009. The private company is based in Hyderabad, India. The Indian company manufactures and supplies pharmaceutical products. |
Pharmaceuticals: Major
|
APL Healthcare Ltd.
 APL Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Part of Aurobindo Pharma Ltd., APL Healthcare Ltd. is a fully integrated pharmaceutical company based in Hyderabad, IN. The private company also has a strong focus on sustainability and social responsibility, with initiatives in place to ensure compliance with social accountability standards, human rights policies, and progressive health and safety practices. APL Healthcare is dedicated to providing access to healthcare and has programs in place to support this goal. The Indian company offers a range of products and services including formulations, custom synthesis, peptides, and R & D. APL Healthcare is committed to quality and safety, with manufacturing facilities approved by various regulatory bodies including the US FDA, UK MHRA, TGA, MCC-SA, EMA, and ANVISA. |
Pharmaceuticals: Major
|
Silicon Life Sciences Pvt Ltd.
 Silicon Life Sciences Pvt Ltd. Medical SpecialtiesHealth Technology Part of Aurobindo Pharma Ltd., Silicon Life Sciences Pvt Ltd. is an Indian company that manufactures non sterile penems. The private company is based in Parawada, India. The company was founded in 2008. Silicon Life Sciences was acquired by Aurobindo Pharma Ltd. on August 10, 2013 for $1.07 million. |
Medical Specialties
|
Eugia Pharma Specialities Ltd.
 Eugia Pharma Specialities Ltd. Miscellaneous Commercial ServicesCommercial Services Eugia Pharma Specialities Ltd. develops, manufactures and markets hormonal and oncology generic formulations. The company is headquartered in Hyderabad, India. |
Miscellaneous Commercial Services
|
Auro Peptides Ltd.
 Auro Peptides Ltd. Chemicals: SpecialtyProcess Industries Part of Aurobindo Pharma Ltd., Auro Peptides Ltd. is an Indian company that manufactures peptides. The private company is based in Hyderabad, India. |
Chemicals: Specialty
|
Apitoria Pharma Pvt Ltd.
| |
Curateq Biologics Pvt Ltd.
| |
Aurobindo Pharma Foundation
|
Investment Trusts/Mutual Funds
|
Lyfius Pharma Pvt Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.36% | 7.95B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- AUROPHARMA Stock
- Company Aurobindo Pharma
